
¹®Á¤ÈÞ ´ëÇ¥¿øÀå
ÀÇÇйڻç /¾È°úÀü¹®ÀÇ / ½Ã·Â±³Á¤,¼ºÇü¾È°ú Àü¹®ÀÇ
¡¤ ¹®¾È°ú ´ëÇ¥¿øÀ塤 °æÈñ´ëÇб³ Àǰú´ëÇÐ ÀÇÇйڻç
¡¤ îñ)´ëÇѾȰúÇÐȸ ºÎȸÀå
¡¤ îñ)¼ö¿ø½ÃÀÇ»çȸ ȸÀå
¡¤ îñ)°æÈñÀÇ´ë ¾È°úÇб³½Çµ¿¹®È¸Àå
¡¤ îñ)µ¿¼ö¿øº´¿ø ¾È°ú°úÀå
¡¤ 1990³â ±¹³» ¶ó½Ä¼ö¼ú µµÀÔ 1¼¼´ë - ½Ã·Â±³Á¤¼ú Áýµµ ÃÑ6¸¸°Ç
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾ç¾È°úÇÐȸ °ø·Î»ó ¼ö»ó
ÁÖ¿äÇØ¿Ü ¿¬¼ö ¹× ÇÐȸ¹ßÇ¥
¡¤ 1991 USA Anaheim ¹Ì±¹¾È°úÇÐȸ¡¤ 1992 USA Sanfrancisco ¹Ì±¹¾È°úÇÐȸ
¡¤ 1994 USA Atlanta ¹Ì±¹¾È°úÇÐȸ
¡¤ 1995 Deutch Achen University ¿¬¼ö
¡¤ 1996 USA Seattle ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 1997 USA Boston ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 2002 Greece À¯·´±¼Àý¼ö¼úÇÐȸ
¡¤ 2007 USA SanDiego ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 2009 USA Sanfrancisco ¹Ì±¹¾È°úÇÐȸ
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇÑ ¾È°úÇÐȸ Á¤È¸¿ø¡¤ ´ëÇÑ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹ ¾È°úÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ Á¤È¸¿ø
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ½É»çÀ§¿ø

¹®¼ö¿µ ¿øÀå
ÀÇÇйڻç / ¾È°úÀü¹®ÀÇ / Àü¾ÈºÎÀü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ÀÇÇйڻ硤 ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç Àü¾ÈºÎ Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¾È°ú ÀÓ»ó °»ç
¡¤ ÇѸ²´ëÇб³º´¿ø ¾È°úÀü°øÀÇ
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø¡¤ Çѱ¹ °Ç¼º¾È ÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(KSCRS) Á¤È¸¿ø
¡¤ ¹Ì±¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(ASCRS) Á¤È¸¿ø
¡¤ Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ Á¤È¸¿ø
¡¤ ´ëÇѰ˾ÈÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ(AAO) Á¤È¸¿ø
¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ(ARVO) Á¤È¸¿ø
¡¤ Çѱ¹¿Ü¾ÈºÎÇÐȸ Á¤È¸¿ø
ÁÖ¿äÇÐȸȰµ¿
¡¤ 2015 AAO(¹Ì±¹¾È°úÇÐȸ) in Las Vegas¡¤ 2016 AAO(¹Ì±¹¾È°úÇÐȸ) in Chicago
¡¤ 2016 ´ëÇоȰúÇÐȸ Ãß°è ¸Á¸· ±¸¿¬
¡¤ 2018 ´ëÇѾȰúÇÐȸ Ãá°è ¸Á¸· ±¸¿¬ ¹× Æ÷½ºÅÍ ¹ßÇ¥
¡¤ 2020 ´ëÇѾȰúÇÐȸ Ãß°è ¿Ü¾ÈºÎ ¹× ¹é³»Àå ±¼Àý ¼ö¼ú ±¸¿¬
¡¤ 2021 ´ëÇѾȰúÇÐȸ Ãá°è ¹é³»Àå ±¼Àý ¼ö¼ú ¿ì¼ö ±¸¿¬
¡¤ 2021 ASCRS(¹Ì±¹ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ) ±¸¿¬
¡¤ 2022 GSLS(±Û·Î¹ú ·»Áî ½ÉÆ÷Áö¾ö) in Las Vegas Æ÷½ºÅÍ ¹ßÇ¥

Á¶°üÇõ ´ëÇ¥ ºÎ¿øÀå
ÀÇÇйڻç/¾È°úÀü¹®ÀÇ/ ¸Á¸·Àü¹®ÀÇ/ Çѱ¹¸Á¸·ÇÐȸÁ¤È¸¿ø
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ¡¤ ºÐ´ç¼¿ï´ëÇб³º´¿ø ¸Á¸·ÀüÀÓÀÇ
¡¤ ÀÇ·á¹ýÀÎ Çѱæ¾È°úº´¿ø ¸Á¸·¼¾ÅÍ °úÀå (°¡Å縯°üµ¿ÀÇ´ë±³¼ö)
¡¤ ¹Ì±¹ÀÇ»çÀÚ°Ý Ãëµæ (USMLE,New York State, United States)
¡¤ ¹Ì±¹ ´º¿å Ä÷³ºñ¾Æ Àǰú´ëÇÐ ¾È°ú¿¬¼ö(Columbia University Medical Center, Edward S. Harkness Eye Institute, New York)
¡¤ ¸¶¸£ÄûÁî ÈĽºÈÄ (Marquis Who¡¯s Who) - ¼¼°è3´ëÀθí»çÀü, ÀÇÇоȰúºÐ¾ßµîÀç
¡¤ û¿Í´ë Àǹ«½Ç ±ºÀǰü (¼öµµ¹æÀ§»ç·ÉºÎ)
¡¤ 2016 ´ëÇѾȰúÇÐȸ Çмú»ó/2017 ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ¿ì¼ö¿¬±¸ÀÚ»ó (APVRS)
¼Ò¼ÓÇÐȸ
¡¤ Çѱ¹¸Á¸·ÇÐȸ º¸ÇèÀ§¿ø / ¼ö¿ø½ÃÀÇ»çȸ Àǹ«À̻硤 ´ëÇѾȰúÇÐȸ / Çѱ¹Æ÷µµ¸·ÇÐȸ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ(AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸(ARVO) Á¤È¸¿ø
¡¤ ¹Ì±¹ Journal of Clinical & Medical Images ³í¹® ½É»çÀ§¿ø
¡¤ ¼ö¿ø½Ã ¾Æµ¿ÀÇ·áÁö¿ø»ç¾÷ ºÎÀ§¿øÀå
ÁÖ¿äÇÐȸ¹ßÇ¥
¡¤ 2014ARVO in Orlando / 2015 AAO in Las Vegas¡¤ 2016 ARVO in Seattle / 2016 AAO in Chicago
¡¤ 2017 ASCRS in Los Angeles / 2017 APVRS in Kuala Lumpur
ÁÖ¿ä³í¹® : (SCI ³í¹® 1ÀúÀÚ¸¸ ±â¼ú, Àü¼¼°è Top 3 ¾È°ú³í¹® 10¿©Æí, ¸ñ·Ï÷ºÎ)
¡¤ ¸Á¸·³»Ãþ ºÒ±ÔÄ¢ Áö¼ö¸¦ ÀÌ¿ëÇÑ ¸Á¸·Àü¸·ÀÇ ¿¹ÈÄ ¿¹Ãø - ¹Ì±¹¾È°úÀú³Î(AJO) 2016¡¤ ¸Á¸·µ¿¸ÆÆó¼â ȯÀÚÀÇ Ç÷Àü ¾ç»ó ºÐ¼® - ¹Ì±¹¾È°úÀú³Î(AJO) 2016
¡¤ ¸Á¸·ºÐÁöÁ¤¸ÆÆó¼â ȯÀÚÀÇ ³úÇ÷°ü ³ªÀÌ ºÐ¼® - ¹Ì±¹½Ã°úÇÐÇÐȸÀú³Î(IOVS) 201
¡¤ ¸Á¸·¹Ú¸® ȯÀÚÀÇ ¼ú ÈÄ ±¼Àý°ª º¯È - ¹Ì±¹¾È°úÀú³Î(AJO) 2014
ÃÖ±Ù SCI ³í¹® ¸ñ·Ï (Á¦ 1ÀúÀÚ¸¸ ±âÀç)
1.Kim MS, Moon JH, Lee MW, Cho KH(2022), Analysis of postoperative intraocular pathologies in patients with mature cataracts. PLoS ONE 17(1): e0263352.2. Kim MS, Lee KM, Hwang JM, Yang HK, Woo SJ. Morphologic Features of Buried Optic Disc Drusen on En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. American Journal of Ophthalmology. 2020 May;213:125-133.
3. Kim MS, Kim JS, Woo SJ. Toxic crystalline retinopathy due to overdose of intravitreal ganciclovir. JAMA Ophthalmol. 2019 Dec 1;137(12)
4. Kim MS, Jeong HY, Cho KH, Oh SW, Byun SJ, Woo SJ, Yang HK, Hwang JM, Park KH, Kim CK, Park SJ. Nonarteritic anterior ischemic optic neuropathy is associated with cerebral small vessel disease. PLoS One. 2019 Nov 14;14(11)
5. Kim MS, Park SJ, Park KH, Woo SJ. Different mechanistic association of myopia with rhegmatogenous retinal detachment between young and elderly patients. Biomed Res Int. 2019 Aug
6. Kim MS, Joo K, Seong MW, Kim MJ, Park KH, Park SS, Woo SJ. Genetic Mutation Profiles in Korean Patients with Inherited Retinal Diseases. J Korean Med Sci. 2019 Jun
7. Kim MS, Hong HK, Park KH, Woo SJ. Intravitreal Dexamethasone Implant with Plasma Autoantibody Monitoring for Cancer-Associated Retinopathy. Korean J Ophthalmol. 2019 Jun; 33(3): 298-300.
8. Kim MS, Hong HK, Ko YJ, Park KH, Ueno S, Okado S, Woo SJ, Joo K. A case of melanoma-associated retinopathy with autoantibodies against TRPM1. Doc Ophthalmol . 2020 May 29.
9. Kim MS, Park SJ, Joo K, Kang HG, Kim M, Woo SJ. Single-Haptic Dislocation of Retropupillary Iris-Claw Intraocular Lens: Outcomes of Reenclavation. Ophthalmic Surg Lasers Imaging Retina . 2020 Jul 1;51(7):384-390.
10. Kim MS, Ryoo NK, Park KH. Laser and Anti-Vascular Endothelial Growth Factor Treatment for Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration. Scientific Reports. 2020 Sep 1;10(1):14370
11. Kim MS, Cho JH, Byun SJ, Oh CM, Park KH, Park SJ. Increased Risk of Cancer in Patients with Retinal Vein Occlusion: A 12-year Nationwide Cohort Study. British Journal of Ophthalmology. 2020-316947
12. Kim MS, Woo SJ, Park KH. Phacovitrectomy versus lens-sparing vitrectomy for rhegmatogenous retinal detachment repair according to the surgical experience. RETINA. (2021 Aug 1;41(8):1597-1604)
13. Kim MS, Choi J, Lee HD, Woo SJ. Dexamethasone intravitreal implant for the treatment of macular edema following retinal vein occlusion: post hoc analysis of post-marketing surveillance data in the real-world setting in Korea. Clinical ophthalmology. 2021 Aug 27;15:3623-3636
14. Kim MS, Hwang JM, Woo SJ. Long-Term Development and Progression of Peripapillary Hyper-reflective Ovoid Mass-like Structures: Two Case Reports. Journal of neuroophthalmology. 2021 Sep 30.

ÃÖÇý¸² ¿øÀå
ÀÇÇм®»ç / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ¡¤ ¼¿ï´ëÇб³º´¿ø ¾È°ú ÀÓ»ó ÀüÀÓ°»ç
¡¤ ¼¿ï´ëÇб³º´¿ø ¾È°ú Àü¹®ÀÇ
¡¤ ¼¿ï´ëÇб³º´¿ø ¼ö·ÃÀÇ
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ¡¤ Çѱ¹Æ÷µµ¸·ÇÐȸ
¡¤ ¹Ì±¹¾È°úÇÐȸ (AAO)
¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ (ARVO)
ÁÖ¿äÇÐȸȰµ¿
¡¤ 2016 ¹Ì±¹¾È°úÇÐȸ (AAO) in Chicago¡¤ 2017 À¯·´¸Á¸·ÇÐȸ (EURETINA) in Barcelona
¡¤ 2018 À¯·´¹é³»Àå±¼Àý¼ö¼úÇÐȸ (ESCRS) in Vienna
ÁÖ¿ä³í¹® (1ÀúÀÚ)
1. Choe HR, Yang HK, Hwang JM, Long-term outcomes of prismatic correction in partially accommodative esotropia. PLoS One. 2019;14(12):e0225654.2. Choe HR, Park WC, Different types of maculopathy between eyes after a high-voltage electrical shock injury. Case Reports in Ophthalmology 2019;10:19-23.
3. Choe HR, Yoon CH, Kim MK, Transplantation of Circumferentially-trephined Autologous Oral Mucosal Graft on Ocular Surface Reconstruction in patients with Limbal Stem Cell Deficiency. Korean J Ophthalmol 2019;33(1):16-25.
4. Choe HR, Kim NJ, Choung HK. Eyeball Displacement into Ethmoid Sinus with Good Visual Restoration. J Korean Ophthalmol Soc 2016;57(9):1472-1475.

¹ÚÀ¯Á¤ ¿øÀå
ÀÇÇм®»ç / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¿Ü·¡±³¼ö¡¤ ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¾È°ú ÀÓ»ó ÀüÀÓ°»ç
¡¤ ¼¿ï¾Æ»êº´¿ø ¾È°ú Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¼ö·ÃÀÇ
¡¤ ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¾È°úÇÐ ¼®»ç ¼ö·á
¡¤ ¿ï»ê´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ (ARVO)
ÁÖ¿äÇÐȸ¹ßÇ¥ (1ÀúÀÚ ¹ßÇ¥)
¡¤ 2017 ¹Ì±¹¾È°úÇÐȸ (ARVO) in Baltimore¡¤ 2019 À¯·´¸Á¸·ÇÐȸ (EURETINA) in Paris
¡¤ 2019 ¾Æ½Ã¾Æ-ÅÂÆò¾ç À¯¸®Ã¼ ¸Á¸·ÇÐȸ (APVRS) in Shanghai
ÁÖ¿ä³í¹® (1ÀúÀÚ)
1. Park YJ, Son GS, Lee YJ et al. Intravitreal Anti-vascular Endothelial Growth Factor Injections to Treat Neovascular Age-related Macular Degeneration: Long-term Treatment Outcomes. J Korean Ophthalmol Soc. 2018;59(12):1142-1151
ÃÖÁøÁÖ ¿øÀå
¾È°úÀü¹®ÀÇ / Àü¾ÈºÎÀü¹®ÀÇ
¡¤ ÇѸ²´ëÇб³ °³²¼º½Éº´¿ø ¾È°úÀü¹®ÀÇ¡¤ ÇѸ²´ëÇб³ °³²¼º½Éº´¿ø ¾È°úÀü°øÀÇ
¡¤ ÇѸ²´ëÇб³ Àǰú´ëÇÐ ¼ö¼®Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø¡¤ Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ(ARVO) Á¤È¸¿ø
ÁÖ¿äÇÐȸ¹ßÇ¥ (1ÀúÀÚ ¹ßÇ¥)
¡¤ 2018 ´ëÇѾȰúÇÐȸ Ãá°è »ç½Ã Æ÷½ºÅÍ ¹ßÇ¥¡¤ 2018 ´ëÇѾȰúÇÐȸ Ãß°è °¢¸· ±¸¿¬
¡¤ 2019 ´ëÇѾȰúÇÐȸ Ãá°è »ç½Ã Æ÷½ºÅÍ ¹ßÇ¥
¡¤ 2019 ´ëÇѾȰúÇÐȸ Ãß°è »ç½Ã Æ÷½ºÅÍ ¹ßÇ¥
¡¤ 2019 ´ëÇѾȰúÇÐȸ Ãß°è °¢¸· ±¸¿¬
ÁÖ¿ä³í¹® (1ÀúÀÚ)
Choi JJ,Kim HK, Yi K, Comparison of the Accuracies of Intraocular Lens Power Formulae by the Type of Implanted Lens. J Korean Ophthalmol Soc 2021;62(3):315-321.
¹®ÀÎÈñ ¿øÀå
¾È°úÀü¹®ÀÇ / ´ëÇѾȰúÇÐȸ Á¤È¸¿ø / ½Ã·Â±³Á¤ Àü¹®ÀÇ
¡¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ °³²¼¼ºê¶õ½ºº´¿ø Àü¾ÈºÎ Àü¹®ÀÇ¡¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¼¼ºê¶õ½ºº´¿ø ¾È°úÀüÀÓÀÇ
¡¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¼¼ºê¶õ½ºº´¿ø ¾È°úÀü°øÀÇ
¡¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¼¼ºê¶õ½ºº´¿ø ¼ö·ÃÀÇ
¡¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø / Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ Á¤È¸¿ø¡¤ Çѱ¹¿Ü¾ÈºÎÇÐȸ / Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ (AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸(ARVO)Á¤È¸¿ø
¡¤ ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¿ì¼ö Àü°øÀÇ ¿¬±¸ ¹ßÇ¥»ó ¼ö»ó
ÁÖ¿äÇÐȸ¹ßÇ¥ (1ÀúÀÚ ¹ßÇ¥)
¡¤ 2016 ARVO in Seattle, US¡¤ 2016 AOPT (Association for Ocular Pharmacology and Therapeutics)in Firenze, Italy
¡¤ 2016 ACS (Asia Comea Society) in Seoul, Korea
¡¤ 2017 AAO in new Orleons, US
ÁÖ¿ä³í¹® (1ÀúÀÚ)
1. Comparison of ocular surface mucin expression after topical ophthalmic drug administration in dry eye-induced mouse model, J Ocul Pharmacol Ther. 2018 Nov:34(9):612-620.2. Intrapapillary hemorrhage with concurrent peripapillary and vitreous hemorrhage in two healthy young patients, BMC Ophthalmol. 2018 Jul 13:18(1):172.
3. Optic Neuropathy Associated with the Use of Phosphodiestrase-5 inhibitors. Korean J Ret 2017:2(2):105-108.
4. The Realationship between Subjective Discomfort and Blepharitis Severity in Dry Eye Patients, J Korean Ophthalmol Soc. 2016 Oct:57(10):1507-1513
5. Recurrent Cystoid Macular Edema Associated with Neurotrophic Kefatitis, J Retin 2016:1(1):51-54